Monopar Therapeutics (MNPR) Return on Capital Employed [ROCE] (2018 - 2026)
Monopar Therapeutics' Return on Capital Employed [ROCE] was -12.85% in Q2 2026, up 5.72 percentage points from -18.57% a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Monopar Therapeutics came in at -14.03%, up 40.54 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +32.68 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -54.56% in FY2024 (+48.98 pp), -103.55% in FY2023 (-26.89 pp), -76.66% in FY2022 (-23.33 pp) and -53.33% in FY2021 (-6.62 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -142.17% (Q4 2023) and -12.57% (Q3 2025) over five years.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 5.72 percentage points); the worst was Q1 2023 (a drop of 56.80 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Monopar Therapeutics | 666.05 Mn | 384.28 Mn | - | -12.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.85% |
| Sep 30, 2025 | -12.57% |
| Jun 30, 2025 | -18.57% |
| Dec 31, 2023 | -142.17% |
| Sep 30, 2023 | -131.32% |
| Jun 30, 2023 | -118.48% |
| Mar 31, 2023 | -109.99% |
| Dec 31, 2022 | -98.41% |
| Sep 30, 2022 | -75.38% |
| Jun 30, 2022 | -68.10% |
| Mar 31, 2022 | -53.18% |
| Dec 31, 2021 | -45.78% |
| Mar 31, 2021 | -35.31% |
| Dec 31, 2020 | -39.84% |
| Sep 30, 2020 | -36.81% |
| Jun 30, 2020 | -37.43% |
| Mar 31, 2020 | -32.03% |
| Dec 31, 2019 | -50.83% |
| Sep 30, 2019 | -82.68% |
| Jun 30, 2019 | -71.43% |
API Access
Monopar Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();